DPP-4 Inhibitor (Type 2 Diabetes)Generally Approved

Sitagliptin

Brand names: Januvia|Last verified: 2026-03-01

FAA Pathway: Standard issuance by AME for well-controlled Type 2 diabetes

Sitagliptin is a DPP-4 inhibitor acceptable for FAA certification. It has a low risk of hypoglycemia when used alone, making it favorable from an aviation safety perspective. Report on your application.

Check your medications

Look up any medication in our FAA compatibility database.

Medication Checker

Pilot Tip

Always report all medications on your FAA medical application (Form 8500-8, Item 17a), even OTC medications. Failure to disclose is a far bigger issue than the medication itself.

Certification Details

Key Requirements
A1C controlled, no hypoglycemic episodes
Certificate Classes
All classes eligible
Hypoglycemia Risk
Low when used as monotherapy
Notes
Report on Form 8500-8 with diabetes documentation

Sources

  • FAA AME Guide — Pharmaceuticals: Diabetes Type II (faa.gov/ame_guide/pharm/oral_diabetes)

Last verified: 2026-03-01

Frequently Asked Questions

Is Sitagliptin allowed for pilots?

The FAA considers Sitagliptin (Januvia) to be "Generally Approved" for medical certification purposes. Sitagliptin is a DPP-4 inhibitor acceptable for FAA certification. It has a low risk of hypoglycemia when used alone, making it favorable from an aviation safety perspective. Report on your application.

What is the FAA status of Sitagliptin?

Sitagliptin has a status of "Generally Approved" under FAA medical certification policy. The certification pathway is: Standard issuance by AME for well-controlled Type 2 diabetes.

Can I fly while taking Sitagliptin?

Sitagliptin is generally compatible with flying. However, you must report it on your FAA medical application (Form 8500-8) and ensure you are not experiencing side effects that could impair flight safety. Always consult your Aviation Medical Examiner (AME).

Important Notice

The FAA does not publish a comprehensive list of “approved” medications. The information on this page represents our interpretation of publicly available FAA guidance and is provided for informational and educational purposes only. It does not constitute medical advice, legal advice, or a guarantee of certification outcome.

The primary issue with the FAA is always whether the underlying medical condition — not just the medication — is compatible with safe flight. You should only start, stop, or change medications after consulting your treating physician. Always consult with a qualified Aviation Medical Examiner (AME) for guidance specific to your situation. FAA policies are subject to change. ClearedMed is not affiliated with or endorsed by the FAA.